20676 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Microorganisms or materials therefrom; Viruses; Subviral particles; Bacteriophages Oncolytic viruses not provided for in groups -
Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
#302ONCOLYTIC VACCINIA VIRUS CANCER THERAPY
#303ONCOLYTIC VIRUS THERAPY
#304Materials and methods for treating cancer
#305Oncolytic poliovirus for human tumors
#306Altered virus
#307GENETICALLY ENGINEERED VACCINIA VIRUSES
#308Therapeutic agents and uses thereof for drugs for treatment of tumors and/or cancers
#309ONCOLYTIC VIRUSES AND THERAPEUTIC MOLECULES
#310Methods and materials for treating cancer
#311METHODS AND COMPOSITIONS FOR CANCER THERAPY
#312Tropism modified cancer terminator virus (Ad.5/3 CTV;Ad.5/3-CTV-M7)
#313RECOMBINANT ONCOLYTIC VIRUS, SYNTHETIC DNA SEQUENCE, AND APPLICATION THEREOF
#314Generation of Tumor Endothelium Specific Viruses
#315Augmentation of Oncolytic Viral Efficacy through Immunological Targeting Tumor Endothelial Cells
#316Recombinant vaccinia virus and use thereof
#317Adenovirus armed with bispecific T cell engager
#318Compositions and methods for enhancing growth, spread, and oncolytic and immunotherapeutic efficacy of oncolytic RNA viruses
#319Oncolytic rhabdovirus expressing IL12
#320High mobility group box I mutant
#321ONCOLYTIC VIRUSES COMPRISING esRAGE AND METHODS OF TREATING CANCER
#322Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell engager
#323Enveloped virus resistant to complement inactivation for the treatment of cancer
#324Method of inducing an oncolytic effect on tumor cells using Zika virus
#325LMP1-expressing cells and methods of use thereof
#326USE OF BCL-XL INHIBITOR AND ONCOLYTIC VIRUS IN PREPARATION OF ANTITUMOR DRUG
#327Oncolytic vaccinia virus mutants and using same for cancer treatment
#328Use of IAP inhibitor and oncolytic virus in preparation of anti-tumor drug
#329Use of VCP inhibitor and oncolytic virus in the preparation of an anti-tumor drug
#330Oncolytic expression vector comprising a nucleic acid comprising a nucleotide sequence encoding GADD34
#331Method of enhancing innate immune responses against a tumor comprising administering lymphocytic choriomeningitis virus (LCMV)
#332EQUIPMENT AND METHODOLOGIES FOR INTRA-TUMORAL INJECTION
#333Oncolytic viruses targeting STAT3
#334CD80 variant immunomodulatory proteins and uses thereof
#335METHODS FOR THE TREATMENT OF BLADDER CANCER
#336Combination method for treatment of cancer
#337Method and System for Killing Cancer Cells Using a Virus
#338Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor
#339HSV VECTORS WITH ENHANCED REPLICATION IN CANCER CELLS
#340Sequential anti-cancer treatment
#341RNA VIRUSES FOR IMMUNOVIROTHERAPY
#342Method for treating cancer with a Coxsackievirus B3 (CVB3) variant
#343Group B adenovirus encoding an anti-TCR-complex antibody or fragment
#344LUNG CANCER THERAPY WITH A PARVOVIRUS
#345INTERLEUKIN-18 VARIANTS AND METHODS OF USE
#346Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy
#347Oncolytic viral delivery of therapeutic polypeptides
#348Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors
#349METHODS FOR COMBINING ADOPTIVE T CELL THERAPY WITH ONCOLYTIC VIRUS ADJUNCT THERAPY
#350Zika virus treatment of CD24-positive tumors and diseases associated with abnormal T cell activation and treating or preventing Zika virus infections
#351Influenza virus vector for virotherapy
#352Seneca valley virus (SVV) cellular receptor targeted oncotherapy
#353Anti-cancer oncolytic virus combination therapies and elite responder selection platforms
#354Virus encoding an anti-TCR-complex antibody or fragment
#355ONCOLYTIC RHABDOVIRUS
#356Method of treatment using oncolytic viruses
#357Targeted cancer therapy
#358Compositions and methods for viral embolization
#359Combination treatment
#360Newcastle disease viruses and uses thereof
#361Modified oncolytic vaccinia viruses expressing a cytokine and a car-boxylesterase and methods of use thereof
#362ONCOLYTIC VACCINIA VIRUS CANCER THERAPY
#363USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT
#364Newcastle Disease Viruses and Uses Thereof
#365Compositions and methods for enhancing virus replication
#366Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
#367Treating cancer with viral nucleic acid
#368Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#369Host regulatory factor that enhances replication and/or propagation of vaccinia virus
#370Use of oncolytic herpes simplex virus, alone or in combination with immune check-point inhibitor, in the treatment of cancer
#371Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
#372Immunomodulatory fusion proteins
#373RECOMBINANT ONCOLYTIC VIRUSES AND USES THEREOF
#374Cancer therapy with a parvovirus combined with a BCL-2 inhibitor
#375Parvovirus formulation for treating tumors
#376Viral Targeting with Knottins
#377VIROTHERAPY WITH AN ANTIBODY COMBINATION
#378Optimized oncolytic viruses and uses thereof
#379Newcastle Disease Viruses And Uses Thereof
#380Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors
#381Myxoma-treated graft material for cancer treatment
#382PSEUDOTYPED ONCOLYTIC VIRAL DELIVERY OF THERAPEUTIC POLYPEPTIDES
#383Cancer therapy with a parvovirus combined with bevacizumab
#384ENHANCED CANCER TREATMENT AND MONITORING USING RECOMBINANT VECTORS
#385Transluminal delivery of viruses for treatment of diseased tissue
#386METHOD OF TREATING A MALIGNANCY IN A SUBJECT AND A PHARMACEUTICAL COMPOSITION FOR USE IN SAME
#387Gene-modified measles virus for tumor treatment use
#388Genetically engineered vaccinia viruses
#389Use of alphavirus in preparation of antitumor drugs
#390Viral vectors and their use in therapeutic methods
#391Use of parvovirus for eliminating cancer stem cells (CSCs)
#392Combination immunotherapy approach for treatment of cancer
#393Oncolytic poliovirus for human tumors
#394Exogenous tap inhibitor armed oncolytic viruses and therapeutic uses thereof
#395Composition for treating cancerous cells and a method therefor
#396Oncolytic virus for expression of immune checkpoint modulators
#397Combination of oncolytic virus with immune checkpoint modulators
#398RNA viruses for immunovirotherapy
#399Macrocyclic lactones and uses thereof as modulators of purinergic receptors
#400Polymer Viral Compositions
#401Microorganisms for therapy
#402Compositions and methods for producing dendritic cells
#403RNA viruses for immunovirotherapy
#404Oncolytic Vaccinia Virus
#405COMBINATION METHOD FOR TREATMENT OF CANCER
#406Method for treating Stage IV melanoma
#407Method for Cancer Therapy Based on Co-Administration of a Parvovirus and a Cytokine
#408Oncolytic virus adjunct therapy with agents that increase virus infectivity
#409Cancer treatment using viruses and camptothecins
#410Mitogen-activated protein kinase-dependent recombinant vaccinia virus (MD-RVV) and use thereof
#411Influenza virus vector for virotherapy
#412In vivo individualized systemic immunotherapeutic method and device
#413METHOD OF TREATING A MALIGNANCY IN A SUBJECT AND A PHARMACEUTICAL COMPOSITION FOR USE IN SAME
#414Immuno-oncolytic therapies
#415Compositions featuring an attenuated Newcastle disease virus and methods of use for treating neoplasia
#416Gene-modified coxsackievirus
#417Myxoma virus mutants for cancer treatment
#418METHODS FOR THE TREATMENT OF BLADDER CANCER
#419VACCINIA VIRUS FOR GENE-DIRECTED ENZYME PRODRUG THERAPY
#420Compositions and methods for enhancing virus replication
#421Oncolytic vaccinia virus cancer therapy
#422Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer
#423Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor
#424Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
#425ONCOLYTIC POLIOVIRUS FOR HUMAN TUMORS
#426NEWCASTLE DISEASE VIRUSES AND USES THEREOF
#427Tropism modified cancer terminator virus (Ad.5/3 CTV;AD.5/3-CTV-M7)
#428ONCOLYTIC VIRUS
#429Oncolytic adenovirus compositions
#430Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapy
#431Treating cancer with viral nucleic acid
#432Pharmaceutical composition
#433Oncolytic rhabdovirus
#434Retroviral vector with mini-promoter cassette
#435METHODS AND COMPOSITIONS FOR TREATMENT OF HEMATOLOGIC CANCERS
#436Oncolytic measles virus
#437ONCOLYTIC VIRUS ENCODING PD-1 BINDING AGENTS AND USES OF THE SAME
#438Lyophilized viral formulations
#439Oncolytic vaccinia virus cancer therapy
#440SOLUBLE GLYCOSAMINOGLYCANASES AND METHODS OF PREPARING AND USING SOLUBLE GLYCOSAMINOGLYCANASES
#441Viral vectors and their use in therapeutic methods
#442Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#443Method of Treating a Malignancy in a Subject and a Pharmaceutical Composition for Use in Same
#444Cancer therapy with a parvovirus combined with an HDAC inhibitor
#445Poxviral oncolytic vectors
#446SENECA VALLEY VIRUS BASED COMPOSITIONS AND METHODS FOR TREATING DISEASE
#447Method for treating or preventing graft versus host disease
#448Co-Administration of a Parvovirus and a Cytokine for Therapy of Pancreatic Cancer
#449Oncolytic vaccinia virus combination cancer therapy
#450Microorganisms for therapy
#451Newcastle Disease Viruses and Uses Thereof
#452VESICULAR STOMATITIS VIRUSES CONTAINING A MARABA VIRUS GLYCOPROTEIN POLYPEPTIDE
#453Use of Antibiotics to Enhance Treatment With Therapeutic Viruses
#454Parvovirus Cancer Therapy and Combination with Chemotherapy
#455Oncolytic viruses and methods for treating neoplastic disorders
#456Delivery of viral agents
#457Oncolytic virotherapy for the therapy of ewing'S sarcoma
#458Cancer combination therapy and recombinant vectors
#459Use of a combination of Myxoma virus and rapamycin for therapeutic treatment
#460Method for orthopoxvirus production and purification
#461ENHANCED TUMOR THERAPY BY TUMOR STEM CELL TARGETED ONCOLYTIC VIRUSES
#462CANCER TREATMENT USING VIRUSES AND CAMPTOTHECINS
#463ONCOLYTIC RHABDOVIRUS
#464AVIAN METAPNEUMOVIRUS IN ONCOLYSIS
#465NEW CLONE OF NEWCASTLE DISEASE VIRUS, ITS MANUFACTURE AND ITS APPLICATION IN THE MEDICAL TREATMENT OF CANCER
#466Oncolytic rhabdovirus
#467Parovirus having a CpG-enriched genome useful for cancer therapy
#468Salmonella bacteriophage and uses thereof
#469Compositions comprising gamma retrovirus vectors and methods of treating proliferative disorders
#470PVRL4 (Nectin4) is a receptor for measles virus
#471Poxviral oncolytic vectors
#472Viral vectors and their use in therapeutic methods
#473Virus clearance of neoplastic cells from mixed cellular compositions
#474Lung cancer therapy using an engineered respiratory syncytial virus
#475Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of its capsid
#476Oncolytic measles virus
#477Use of parvovirus for eliminating cancer stem cells (CSCs)
#478RECOMBINANT REPLICATION COMPETENT ONCOLYTIC VIRUSES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CANCER
#479Modified parvovirus having enhanced anti-tumor efficacy
#480Methods and compositions concerning poxviruses and cancer
#481USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT
#482Methods and Compositions for Treatment of Hematologic Cancers
#483Modified rodent parvovirus capable of propagating and spreading through human gliomas
#484CO-ADMINISTRATION OF A PARVOVIRUS AND A CYTOKINE FOR THERAPY OF PANCREATIC CANCER
#485Microorganisms for imaging and/or treatment of tumors
#486Genetically modified paramyxovirus for treatment of tumor diseases
#487COMBINATION VIROTHERAPY FOR CANCER
#488Cancer Therapy with a Parvovirus Combined with an HDAC Inhibitor
#489POXVIRAL ONCOLYTIC VECTORS
#490Modified Oncolytic Viruses
#491Clonal strains of attenuated vaccinia viruses and methods of use thereof
#492METHOD AND COMPOSITION FOR CREATING CONDITIONAL LETHALITY FOR VIRUS MUTANTS AND FOR ELIMINATING THE VIABILITY OF AN EUKARYOTIC CELL
#493Oncolytic vaccinia virus cancer therapy
#494Microorganisms for therapy
#495Oncolytic rhabdovirus
#496Microorganisms for imaging and/or treatment of tumors
#497Oncolytic virotherapy for prevention of tumor recurrence
#498Oncolytic vaccinia virus combination cancer therapy
#499Parvovirus methods and compositions for killing neoplastic cells
#500Method for brain cancer therapy by co-administration of a parvovirus and interferon-gamma
#501Lyophilized viral formulations
#502Immortalized avian cell lines and use thereof
#503Oncolytic viruses and methods for treating neoplastic disorders
#504Attenuated poliovirus
#505Method for orthopoxvirus production and purification
#506MICROORGANISMS FOR PREVENTING AND TREATING NEOPLASMS ACCOMPANYING CELLULAR THERAPY
#507Seneca valley virus based compositions and methods for treating disease
#508TUMOR THERAPY WITH ANTITUMOR AGENTS IN COMBINATION WITH SINDBIS VIRUS-BASED VECTORS
#509Microorganisms for therapy
#510Therapeutic/prophylactic agent for prostate cancer
#511IMMORTALIZED AVIAN CELL LINES AND USE THEREOF
#512Virus clearance of neoplastic cells from mixed cellular compositions
#513USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT
#514Myxoma virus mutants for cancer treatment
#515MEASLES VIRUS FOR THE ELIMINATION OF UNWANTED CELL POPULATIONS
#516Clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer
#517Viral vectors and their use in therapeutic methods
#518MICROORGANISMS FOR PREVENTING AND TREATING NEOPLASMS ACCOMPANYING CELLULAR THERAPY
#519Poxviral oncolytic vectors
#520Oncolytic rhabdovirus
#521AMPLIFICATION OF CANCER-SPECIFIC ONCOLYTIC VIRAL INFECTION BY HISTONE DEACETYLASE INHIBITORS
#522Poxviral oncolytic vectors
#523Parvovirus having a CPG-enriched genome useful for cancer therapy
#524Parvovirus cancer therapy and combination with chemotherapy
#525RECOMBINANT NEWCASTLE DISEASE VIRUS
#526Transluminal delivery of oncoltyic viruses for cancer therapy
#527ADJUVANT
#528Methods and compositions for treatment of cancer using oncolytic RSV activity
#529ONCOLYTIC VACCINIA VIRUS CANCER THERAPY
#530Microorganisms for imaging and/or treatment of tumors
#531Method for treating stage IV melanoma
#532Sickled Erythrocytes, Nucleated Precursors & Erythroleukemia Cells for Targeted Delivery of Oncolytic Viruses, Anti-tumor Proteins, Plasmids, Toxins, Hemolysins & Chemotherapy
#533Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods
#534Seneca Valley virus based compositions and methods for treating disease
#535Method for limiting the growth of cancer cells using an attenuated measles virus
#536COMPOSITIONS AND METHODS FOR TREATEMENT OF CANCER
#537TREATING CANCER WITH VIRAL NUCLEIC ACID
#538METHOD AND COMPOSITION FOR TREATMENT OF NEOPLASMS
#539ATTENUATED ONCOLYTIC PARAMYXOVIRUSES ENCODING AVIAN CYTOKINES
#540Method of Treating a Malignancy in a Subject Via Direct Picornaviral-Mediated Oncolysis
#541Microorganisms for therapy
#542Microorganisms for therapy
#543Use of Myxoma virus for the therapeutic treatment of cancer and chronic viral infection
#544USE OF A VIRUS REGIMEN FOR THE TREATMENT OF DISEASES
#545Attenuated poliovirus
#546Tumor therapy with replication competent sindbis viral vectors
#547ANTI-TUMOR EFFECTIVE PARAMYXOVIRUS
#548Oncolytic virus therapy
#549ADMINISTRATION OF THERAPEUTIC VIRUSES
#550Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods
#551Systems and methods for viral therapy
#552Methods for treating malignancies using coxsackieviruses
#553Parvovirus methods and compositions for killing neoplastic cells
#554Microorganisms for imaging and/or treatment of tumors
#555USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT
#556Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer
#557Methods and compositions concerning poxviruses and cancer
#558Method for limiting the growth of cancer cells using an attenuated measles virus
#559Systemic Treatment of Metastatic and/or Systemically-Disseminated Cancers using GM-CSF-Expressing Poxviruses
#560Recombinant Newcastle Disease Virus
#561Methods and compositions for treatment of hematologic cancers
#562Method and Composition for Treatment of Neoplasms
#563Anti-Cancer and Anti-Infectious Disease Compositions and Methods for Using Same
#564Flavivirus Replicon Constructs for Tumor Therapy
#565Recombinant adeno-associated virus expressing human antisense gene CyP2J2 and its preparation methods
#566Methods and Compositions for Treating Tumors
#567Recombinant alphavirus vectors and methods of using same
#568Treatment of neoplasms with viruses
#569Modified oncolytic viruses
#570Anticancer Agent Containing Minus-Strand Rna Virus
#571Anticancer agent containing dendritic cell having RNA virus transferred thereinto
#572GRP78 targeting peptides and methods employing same
#573Microorganisms for therapy
#574CANCER TREATMENT USING VIRUSES AND CAMPTOTHECINS
#575Microorganisms for therapy
#576PURGING OF CELLS USING VIRUSES
#577Compositions of NDV and methods of use thereof for treatment of cancer
#578Newcastle disease virus administration
#579Method for limiting the growth of cancer cells using an attenuated measles virus
#580Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
#581Mutants of vaccinia virus as oncolytic agents
#582Microorganisms for therapy
#583Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection
#584Methods of treating and detecting cancer using viruses
#585Replication competent virus or its recombinant for use in cancer therapy
#586Treating hepatocellular carcinomas using therapeutic viruses
#587Seneca Valley virus based compositions and methods for treating disease
#588Method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
#589Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
#590Methods and compositions concerning poxviruses and cancer
#591Anti-cancer virus desensitization method
#592Microorganisms for therapy
#593Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent
#594Method for treating human tumor cells with a newcastle disease virus strain having a p53 independent oncolytic effect
#595Administration of therapeutic viruses
#596Oncolytic virus therapy
#597Compositions and methods of use of targeting peptides for diagnosis and therapy
#598Microorganisms for therapy
#599Compositions and methods for treatment of cancer
#600Pharmaceutical composition for treatment of cancers